JANUARY 12TH, 2022 CONN HASTINGS MATERIALS, MEDICINE, NANOMEDICINE, ONCOLOGY Researchers at Penn State working with collaborators have developed a nanomaterial that can ‘mop up’ chemotherapeutics in the bloodstream, helping to reduce off-target effects. The technology is intended for use in situations where a chemotherapeutic can be delivered precisely to the site of a tumor, and not...
